Garrison Asset Management, LLC Astrazeneca PLC Transaction History

Garrison Asset Management, LLC

$190 Million
Q3 2024

A detailed history of Garrison Asset Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Garrison Asset Management, LLC holds 8,045 shares of AZN stock, worth $573,125. This represents 0.33% of its overall portfolio holdings.

Number of Shares

8,045

Previous 8,070 0.31%

Holding current value

$573,125

Previous $629,000 0.48%

% of portfolio

0.33%

Previous 0.34%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$76.67 - $87.62 $1,916 - $2,190	-25 Reduced 0.31%	8,045 $626,000
Q2 2024 Aug 08, 2024	SELL	$66.81 - $80.83 $1,336 - $1,616	-20 Reduced 0.25%	8,070 $629,000
Q3 2023 May 24, 2024	SELL	$64.85 - $71.7 $14,202 - $15,702	-219 Reduced 2.64%	8,090 $547,000
Q3 2023 Oct 23, 2023	SELL	$64.85 - $71.7 $9,662 - $10,683	-149 Reduced 1.81%	8,090 $548,000
Q2 2023 May 24, 2024	SELL	$69.91 - $75.81 $10,626 - $11,523	-152 Reduced 1.8%	8,309 $594,000
Q2 2023 Aug 03, 2023	SELL	$69.91 - $75.81 $15,520 - $16,829	-222 Reduced 2.62%	8,239 $589,000
Q1 2023 May 24, 2024	SELL	$63.15 - $71.6 $10,167 - $11,527	-161 Reduced 1.87%	8,461 $587,000
Q1 2023 Apr 28, 2023	SELL	$63.15 - $71.6 $10,167 - $11,527	-161 Reduced 1.87%	8,461 $587,000
Q4 2022 May 24, 2024	BUY	$54.21 - $70.44 $28,839 - $37,474	532 Added 6.58%	8,622 $584,000
Q4 2022 Feb 07, 2023	SELL	$54.21 - $70.44 $5,421 - $7,044	-100 Reduced 1.15%	8,622 $585,000
Q3 2022 Oct 21, 2022	SELL	$53.02 - $135.75 $1,219 - $3,122	-23 Reduced 0.26%	8,722 $478,000
Q2 2022 Aug 08, 2022	SELL	$59.26 - $71.14 $8,000 - $9,603	-135 Reduced 1.52%	8,745 $578,000
Q1 2022 May 09, 2022	SELL	$55.72 - $67.12 $891 - $1,073	-16 Reduced 0.18%	8,880 $589,000
Q4 2021 Jan 25, 2022	BUY	$54.02 - $63.83 $1,944 - $2,297	36 Added 0.41%	8,896 $518,000
Q3 2021 Oct 20, 2021	SELL	$55.56 - $60.79 $6,389 - $6,990	-115 Reduced 1.28%	8,860 $532,000
Q2 2021 Jul 21, 2021	SELL	$48.42 - $60.18 $2,372 - $2,948	-49 Reduced 0.54%	8,975 $538,000
Q1 2021 Apr 21, 2021	BUY	$47.16 - $54.44 $40,982 - $47,308	869 Added 10.66%	9,024 $449,000
Q4 2020 Feb 02, 2021	SELL	$48.52 - $58.02 $619,212 - $740,451	-12,762 Reduced 61.01%	8,155 $408,000
Q3 2020 Oct 28, 2020	SELL	$53.07 - $61.1 $7,005 - $8,065	-132 Reduced 0.63%	20,917 $1.15 Million
Q2 2020 Aug 06, 2020	SELL	$43.1 - $55.31 $22,843 - $29,314	-530 Reduced 2.46%	21,049 $1.11 Million
Q1 2020 May 04, 2020	SELL	$37.79 - $51.33 $61,219 - $83,154	-1,620 Reduced 6.98%	21,579 $964,000
Q4 2019 Feb 10, 2020	SELL	$42.46 - $50.46 $30,783 - $36,583	-725 Reduced 3.03%	23,199 $1.16 Million
Q3 2019 Nov 08, 2019	SELL	$40.12 - $45.47 $10,912 - $12,367	-272 Reduced 1.12%	23,924 $1.07 Million
Q2 2019 Jul 25, 2019	SELL	$37.28 - $41.68 $4,846 - $5,418	-130 Reduced 0.53%	24,196 $999,000
Q1 2019 May 06, 2019	BUY	$35.49 - $43.02 $8,340 - $10,109	235 Added 0.98%	24,326 $984,000
Q4 2018 Feb 06, 2019	BUY	$36.86 - $41.49 $187,949 - $211,557	5,099 Added 26.85%	24,091 $915,000
Q4 2018 Feb 05, 2019	SELL	$36.86 - $41.49 $198,822 - $223,797	-5,394 Reduced 22.12%	18,992 $624,000
Q3 2018 Nov 02, 2018	BUY	$34.76 - $39.72 $19,257 - $22,004	554 Added 2.32%	24,386 $965,000
Q2 2018 Aug 10, 2018	BUY	$34.55 - $37.05 $181,836 - $194,994	5,263 Added 28.34%	23,832 $837,000
Q4 2017 Jan 30, 2018	BUY	$32.09 - $34.78 $12,226 - $13,251	381 Added 2.09%	18,569 $644,000
Q3 2017 Oct 30, 2017	BUY	$28.96 - $34.0 $526,724 - $618,392	18,188	18,188 $616,000

Others Institutions Holding AZN

# of Institutions

1,335

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Garrison Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garrison Asset Management, LLC with notifications on news.

Account

Garrison Asset Management, LLC Astrazeneca PLC Transaction History